Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm:
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2017 · fourth_quarter · 4A
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Source: Senate LDA
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
Removing Barriers to Colorectal Cancer Screening Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Removing Barriers to Colorectal Cancer Screening Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the American Health Care Act, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller-Johnson repeal bill. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, Removing Barriers to Colorectal Cancer Screening Act; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Removing Barriers to Colorectal Cancer Screening Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Removing Barriers to Colorectal Cancer Screening Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Removing Barriers to Colorectal Cancer Screening Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including the American Health Care Act. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, Removing Barriers to Colorectal Cancer Screening Act; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Removing Barriers to Colorectal Cancer Screening Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Removing Barriers to Colorectal Cancer Screening Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the American Health Care Act and the Better Care Reconciliation Act. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, Removing Barriers to Colorectal Cancer Screening Act; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Commute Less Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Commute Less Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Commute Less Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Commute Less Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
FDA Deeming Authority Clarification Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
FDA Deeming Authority Clarification Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
FDA Deeming Authority Clarification Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
FDA Deeming Authority Clarification Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
FDA Deeming Authority Clarification Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
FDA Deeming Authority Clarification Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
FDA Deeming Authority Clarification Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
RACE for Children Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
RACE for Children Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
RACE for Children Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
RACE for Children Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
RACE for Children Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
RACE for Children Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
Cancer Drug Parity Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Cancer Drug Parity Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Cancer Drug Parity Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Cancer Drug Parity Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
American Health Care Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the American Health Care Act, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller-Johnson repeal bill. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, Removing Barriers to Colorectal Cancer Screening Act; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
American Health Care Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
American Health Care Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
American Health Care Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
American Health Care Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the American Health Care Act and the Better Care Reconciliation Act. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, Removing Barriers to Colorectal Cancer Screening Act; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
American Health Care Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
To amend title 38, United States Code, to prohibit smoking in any facility of the Veterans Health Administration, and for other purposes.
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
To amend title 38, United States Code, to prohibit smoking in any facility of the Veterans Health Administration, and for other purposes.
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
To amend title 38, United States Code, to prohibit smoking in any facility of the Veterans Health Administration, and for other purposes.
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
To amend title 38, United States Code, to prohibit smoking in any facility of the Veterans Health Administration, and for other purposes.
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Palliative Care and Hospice Education and Training Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
Palliative Care and Hospice Education and Training Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
Palliative Care and Hospice Education and Training Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Palliative Care and Hospice Education and Training Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; and, H.R.820 & S.292, Childhood Cancer STAR Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
Palliative Care and Hospice Education and Training Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Palliative Care and Hospice Education and Training Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Palliative Care and Hospice Education and Training Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Veterans Affairs Medical Scribe Pilot Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Veterans Affairs Medical Scribe Pilot Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Veterans Affairs Medical Scribe Pilot Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Veterans Affairs Medical Scribe Pilot Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Universal Charitable Giving Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
Universal Charitable Giving Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
Universal Charitable Giving Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
Universal Charitable Giving Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Common Sense Nutrition Disclosure Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
Common Sense Nutrition Disclosure Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
Common Sense Nutrition Disclosure Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; and, H.R.820 & S.292, Childhood Cancer STAR Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
Common Sense Nutrition Disclosure Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Common Sense Nutrition Disclosure Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Common Sense Nutrition Disclosure Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Common Sense Nutrition Disclosure Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Childhood Cancer STAR Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
Childhood Cancer STAR Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
Childhood Cancer STAR Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Childhood Cancer STAR Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Childhood Cancer STAR Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; and, H.R.820 & S.292, Childhood Cancer STAR Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
Childhood Cancer STAR Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Childhood Cancer STAR Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Right to Try Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Right to Try Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Right to Try Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Right to Try Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Lymphedema Treatment Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Lymphedema Treatment Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Lymphedema Treatment Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Lymphedema Treatment Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
U.S. OUTDOOR Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
U.S. OUTDOOR Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
U.S. OUTDOOR Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
U.S. OUTDOOR Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Lower Premiums Through Reinsurance Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Lower Premiums Through Reinsurance Act of 2017
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Federal budget and appropriations for cancer research and programs, including: FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act; and issues relating to veterans cancer screenings with respect to the Military Construction and Veterans Affairs Appropriations Act.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2017 · fourth_quarter · 4A
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
Federal budget and appropriations for cancer research and programs, including: FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act; and issues relating to veterans cancer screenings with respect to the Military Construction and Veterans Affairs Appropriations Act.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2017 · fourth_quarter · 4A
Federal budget and appropriations for cancer research and programs, including: FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act; and issues relating to veterans cancer screenings with respect to the Military Construction and Veterans Affairs Appropriations Act.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2017 · fourth_quarter · Q4
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Federal budget and appropriations for cancer research and programs, including: FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act; and issues relating to veterans cancer screenings with respect to the Military Construction and Veterans Affairs Appropriations Act.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2017 · third_quarter · Q3
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the American Health Care Act, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller-Johnson repeal bill. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, Removing Barriers to Colorectal Cancer Screening Act; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Federal budget and appropriations for cancer research and programs, including: FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act. Also, issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2017 · second_quarter · Q2
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the American Health Care Act and the Better Care Reconciliation Act. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, Removing Barriers to Colorectal Cancer Screening Act; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2017 · first_quarter · Q1
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including the American Health Care Act. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, Removing Barriers to Colorectal Cancer Screening Act; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2016 · fourth_quarter · 4A
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2016 · fourth_quarter · 4A
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including certain votes on issues relating to NIH and cancer moonshot funding in the context of H.R. 2028, the Continuing and Security Assistance Appropriations Act; and, H.R. 34, the 21st Century Cures Act. Also issues relating to non-communicable diseases with respect to S.3117, the State/Foreign Operations FY17 Appropriations legislation, the House companion draft Appropriations bill, and the Continuing Resolution for FY17 enacted prior to October 1, 2016.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2016 · fourth_quarter · Q4
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2016 · third_quarter · Q3
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including certain votes on H.R.2577, FY17 THUD - MIL CON Appropriations legislation; the Affordable Care Act provisions; and programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H.R.5054, the House FY17 Agriculture Appropriations legislation and S.2956, the Senate companion Appropriations bill; S.3040, the Senate FY17 Labor, Health and Human Services Appropriations legislation and the un-numbered House companion Appropriations bill; issues relating to NIH funding in the context of the Senate HELP Committee Medical Innovation legislation; and the House-passed 21st Century Cures legislation. Also issues relating to non-communicable diseases with respect to S.3117, the State/Foreign Operations FY17 Appropriations legislation, the House companion draft Appropriations bill, and the Continuing Resolution for FY17 enacted prior to October 1, 2016.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2016 · second_quarter · Q2
Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including certain votes on H.R.2577, FY17 THUD - MIL CON Appropriations legislation; the Affordable Care Act provisions; and programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H. Con. Res. 25, the FY17 budget resolution, H.R.5054, the House FY17 Agriculture Appropriations legislation and S.2956, the Senate Companion Appropriations bill; S.3040, the Senate FY17 Labor, Health and Human Services Appropriations legislation and the un-numbered House Companion Appropriations bill; issues relating to NIH funding in the context of the Senate HELP Committee Medical Innovation legislation; and the House-passed 21st Century Cures legislation. Also issues relating to non-communicable diseases with respect to S.3117, the State/Foreign Operations FY17 Appropriations legislation and the House Companion draft Appropriations bill.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2016 · first_quarter · 1A
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in H.R.__, FY17 Agriculture Appropriations legislation.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2016 · first_quarter · Q1
Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; and programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H. Con. Res. 25, the FY17 budget resolution, H.R.__, the FY17 Agriculture Appropriations legislation and issues relating to NIH funding in the context of the Senate HELP Committee Medical Innovation legislation.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in H.R.__, FY17 Agriculture Appropriations legislation.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2015 · fourth_quarter · 4A
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, product regulation, and smokefree environments, including implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430,Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to tobacco control related appropriated accounts, including CDC's Office of Smoking & Health in H.R.2029, Omnibus Appropriations legislation.
Issues relating to the tax treatment of nonprofits, charitable IRA rollover within tax extenders legislative proposals, including governance of nonprofit organizations.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2015 · fourth_quarter · Q4
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H.R.6, the 21st Century Cures Act; H.R.3020/S.1695, Departments of Labor HHS Appropriations legislation for FY16; H.R.2772, S.1725, Department of State, Foreign Operations Appropriations for FY16; S.1558, Department of Defense Appropriations Act; and H.R.2029, Mil-Con Veterans Affairs (Omnibus) Appropriations Act.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2015 · third_quarter · Q3
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act of 2015; and H.R.1190, Protecting Seniors' Access to Medicare Act.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; legislation relating to trade promotion authority; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2015 · second_quarter · Q2
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations: (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC) and tobacco tax proposals contained in the President's FY16 Budget. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; legislation relating to trade promotion authority; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues relating to inclusion of palliative care as a bundled service within CMS quality based payment programs and H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act of 2015; H.R.2810 & H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015 and issues within related to Federally Qualified Health Centers; and H.R.1190, Protecting Seniors' Access to Medicare Act.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2015 · first_quarter · Q1
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including follow-on legislation to H.R.1666 & S.2800, the Patient Centered Quality Care for Life Act, and, H.R.1339 (IH) & S.641, the Palliative Care and Hospice Education and Training Act (113th Congress), H.R.716 & S.370, the Breast Density & Mammography Reporting Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, colorectal cancer screening tests, electronic medical devices, and issues relating to the 21st Century Cures Initiative of the House Energy & Commerce Committee and Senate HELP Committee.
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H.Con.Res.27 & S.Con.Res.11, FY16 proposed budget resolutions, H.R.531 and S.318, the Accelerating Biomedical Research Act.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2014 · fourth_quarter · Q4
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", and H.R.1070 & S.2348, Removing Barriers to Colorectal Cancer Screening Act of 2013; H.R.2810, Medicare Patient Access & Quality Improvement Act, S.1871, the SGR Repeal & Medicare Beneficiary Access Act, and S. 2157, the Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including H.R.1666 & S.2800, the Patient Centered Quality Care for Life Act, and, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act; S.621 and H.R.2607 & S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.5145 & S.2622, the Breast Density & Mammography Reporting Act, H.R.4250 and S.2141, the Sunscreen Innovation Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, colorectal cancer screening tests, electronic medical devices, and issues relating to the 21st Century Cures Initiative of the House Energy & Commerce Committee.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2014 · third_quarter · Q3
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including H.R.1666 & S.2800, the Patient Centered Quality Care for Life Act, and, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act; S.621 and H.R.2607 & S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood CancerSurvivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.5145 & S.2622, the Breast Density & Mammography Reporting Act, H.R.4250 and S.2141, the Sunscreen Innovation Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, colorectal cancer screening tests, electronic medical devices, and issues relating to the 21st Century Cures Initiative of the House Energy & Commerce Committee.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2014 · first_quarter · 1A
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and Prevention America Act, H.R.792 & S.772, cigar exemptionfrom FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY15 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership, and legislation relating to trade promotion authority.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", general deficit reduction issues impacting Medicare & Medicaid, and H.R.1070, Removing Barriers to Colorectal Cancer Screening Act of 2013; H.R.2810, Medicare Patient Access & QualityImprovement Act, S.1871, the SGR Repeal & Medicare Beneficiary Access Act, and S. 2157, the Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2014 · second_quarter · Q2
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including H.R.1666, the Patient Centered Quality Care For Life Act, and, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act; S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Qualityof Life Act;H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.5145 & S.2622, the Breast Density & Mammography Reporting Act, H.R.4250 and S.2141, the Sunscreen Innovation Act, and regulations relating to tanning beds.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations: (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and PreventionAmerica Act, H.R.792 & S.772, cigar exemption from FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY15 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership, and legislation relating to trade promotion authority.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2014 · first_quarter · Q1
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY15 Budget.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; H.R.1666, the Patient Centered Quality Care For Life Act, and, H.R.1339 & S.641, the Palliative Care andHospice Education and Training Act; S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.3404, the Breast Density & Mammography Reporting Act, H.R.4250 and S.2141, legislation to create a new FDA approval pathway for O.T.C. sunscreen products.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2013 · fourth_quarter · Q4
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. S.1284, the FY14 Labor, Health & Human Resources Appropriations Act; H.J.Res.59, Continuing Resolution; H.R.2775, Continuing Appropriations; and H.R.3547,Omnibus Appropriations for FY14, and matters relating to the impact of the government-wide sequester as it affects CDC, NIH, NCI, Prevention & Public Health Fund, and other appropriated accounts relating to cancer.
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY14 Budget.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2013 · third_quarter · Q3
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY14 Budget.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; and H.R.1666, the Patient Centered Quality Care For Life Act. Also, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act;S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2013 · second_quarter · 2A
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY14 Budget.
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. S.Con.Res. 8 FY14 Senate Budget Resolution, H.J.Res.117, the Continuing Appropriations Resolution Act; the President's FY14 Budget; and S.1284, the FY14 Labor,Health & Human Resources Appropriations Act.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2013 · first_quarter · 1A
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid, including: S.868 and H.R.1683, the State Flexibility Act (MOE). Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", S.2068, S.2288, H.R.1206, the Access to Independent Health Insurance Advisors Act of 2012, general deficit reduction issues impacting Medicare &Medicaid.
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY14 Budget.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2013 · second_quarter · Q2
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act; S. 621 and H.R. 1285, the Safe Prescribing Act;H.R. 1366, the Stop Oxy Abuse Act; and issues relating to tanning beds before the FDA, HHS and the House and Senate.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2013 · first_quarter · Q1
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY14 Budget.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2012 · fourth_quarter · Q4
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including discussion leading up to enactment of 2013 fiscal cliff legislation, governance of nonprofit organizations, the Public Good IRA Rollover Act, S. 557, legislation relating to tax extenders, and issues under consideration by the Joint Select Committee on Deficit Reduction.
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, and international health. H.J.Res.117, the Continuing Appropriations Resolution Act; S.3295, the Labor, HHS, Education Appropriations Act, and similar legislation pending in the House of Representatives.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2012 · third_quarter · Q3
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC); and (4) issues relating to NIH reorganization. Legislation includes H.R.3186 and S.1706, Smuggled Tobacco Prevention Act; H.R.3382, Smoke-Free Federal Building Act; S.1403, IDEA Full Funding Act; and H.R.65: Candy Tobacco Tax Parity Act of 2011. Issues related to cigar regulation on H.R.5973.
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, governance of nonprofit organizations, the Public Good IRA Rollover Act, S. 557, legislation relating to tax extenders, and issues under consideration by the Joint Select Committee on Deficit Reduction.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2012 · second_quarter · Q2
Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493; H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R. 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S. 1064, the Sun Act; S 965, the Family Act; H.R. 2954, Health Equity and Accountability Act of 2011; and H.R. 2077, the MLR Repeal Act; H.R. 2245 and S. 296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R. 4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S. 2515, the Clean Cookstoves Support Act of 2012.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2012 · first_quarter · Q1
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, and international health. Legislation includes H. Con. Res. 34, establishing the budget for the US Government for FY 2012; and issues relating to consolidation of categorized cancer prevention programs of the Centers for Disease Control and Prevention.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid, including: S. 868 and H.R. 1683, the State Flexibility Act (MOE).
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2011 · fourth_quarter · Q4
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, governance of nonprofit organizations, the Public Good IRA Rollover Act, S. 557, legislation relating to tax extenders, and issues under consideration by the Joint Select Committee on Deficit Reduction.
Issues relating to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; HR 2941 and S 3493; HR 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; HR 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S. 1064, the Sun Act; S 965, the Family Act; HR2954, Health Equity and Accountability Act of 2011; and HR 2077, the MLR Repeal Act; H.R. 2245 and S. 296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, and issues relating to the ongoing national shortage of cancer drugs.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2011 · third_quarter · Q3
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) legislation regarding Congressional review/approval of regulations, including H.R. 10, the Regulations from the Executive in Need of Scrutiny A Act of 2011; (4) Framework Convention on Tobacco Control (FCTC); and (5) issues relating to NIH reorganization.
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, and international health; and matters under consideration by the Joint Select Committee on Deficit Reduction. Legislation includes H. Con. Res. 34, establishing the budget for the US Government for FY 2012; S. 1599, draft House text of legislation making appropriations for L-HHS FY 12; and S. 365, the Budget Control Act of 2011.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2011 · second_quarter · Q2
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC and for the Prevention & Public Health Fund, the Affordable Care Act provisions, breast and cervical programs, colorectal cancer programs, tobacco regulation & cessation programs, patient navigator programs, and international health programs, and H. Con. Res. 34, establishing the budget for the U.S. Government for FY 2012.
Issues related to implementation of changes to Medicare and Medicaid, pursuant to P.L.111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S.717 and H.R.6224, H. Con. Res. 34, establishing a budget for the U.S. Government for FY12, S.868 and H.R.1683, the State Flexibility Act (MOE).
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2011 · first_quarter · Q1
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations and Public Good IRA Rollover Act, S.557, legislation relating to tax extenders.
Issues related to implementation of changes to Medicare and Medicaid, pursuant to P.L.111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S.717 and H.R.6224, H. Con. Res. 34, establishing a budget for the U.S. Government for FY12.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2010 · fourth_quarter · Q4
Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.717, and H.R.6224, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; S.488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R.5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493, Johanna's Law reauthorization; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.2366, the Cancer Drug Coverage Act of 2009; H.R.4662, The Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010; and child nutrition reauthorization bills (H.R.5504, Improving Nutrition for America's Children Act, and S.3307, Healthy, Hunger-Free Kids Act).
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2010 · third_quarter · Q3
Issues related to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including implementation of the Family Smoking Prevention and Tobacco Control Act (P.L.111-31), H.R.1850, the Quit Smoking for Life Act, and related cessation legislation, and cessation and prevention programs authorized as part of P.L.111-148, the Patient Protection & Affordable Care Act of 2010, the Prevent All Cigarette Trafficking Act (PACT Act - H.R.1676 and S.1147), and the Framework Convention on Tobacco Control (FCTC).
Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.717, and H.R.6224, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; S.488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R.5560, the Quality Cancer Care for Life Act of 2010; the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010; and child nutrition reauthorization bills (H.R.5504, Improving Nutrition for America's Children Act, and S.3307, Healthy, Hunger-Free Kids Act).
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2010 · second_quarter · Q2
Issues related to smoking cessation, tobacco taxes, and product regulation, including implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), H.R. 1850, the Quit Smoking for Life Act, and related cessation legislation.
Issues related to health care reform, Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 2291, the Medicare Early Detection of Cancer Promotion Act. Issues relating to implentation of Medicare & Medicaid related provisions enacted as part of P.L.111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S. 717 the 21st Century Cancer ALERT Act.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2010 · first_quarter · Q1
Issues related to health disparities, health care reform, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H. R. 756 & S. 660, National Pain Care Policy Act; H. R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 717, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; and S. 488, the Access to Cancer Clinical Trials Act of 2009, and H.R.1740 and S. 994, Breast Cancer Education &Awareness Requires Learning Young Act ("EARLY"). Issues relating to health care reform in H.R. 3590 The Patient Protection & Affordable Care Act and H.R. 4872, the Health Care & Education Reconciliation Act of 2010, the health care reform bills.
Issues related to smoking cessation, tobacco taxes, and product regulation and implementation, including H.R. 1256, Family Smoking Prevention and Tobacco Control Act, and H.R. 1850, the Quit Smoking for Life Act, and related cessation legislation.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2009 · fourth_quarter · Q4
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, and patient navigator programs, H.R. 3293 Labor - HHS Appropriations for FY10.
Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H. R. 756 & S. 660, National Pain Care Policy Act; H. R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 717, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; and S. 488, the Access to Cancer Clinical Trials Act of 2009, and H.R.1740 and S. 994, Breast Cancer Education & Awareness Requires Learning Young Act ("EARLY").
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2009 · third_quarter · 3A
Issues related to smoking cessation, tobacco taxes, and product regulation and implementation, including H.R. 1256, Family Smoking Prevention and Tobacco Control Act, and tobacco tax aspects of H.R. 2, the SCHIP legislation, and H.R. 1850, the Quit Smoking for Life Act.
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, and patient navigator programs, H.R. 3293 Labor - HHS Appropriations for FY10.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2009 · third_quarter · Q3
Issues related to smoking cessation, tobacco taxes, and product regulation and implementation, including H.R. 1256, Family Smoking Prevention and Tobacco Control Act, and tobacco tax aspects of H.R. 2, the SCHIP legislation, and H.R. 1850, the Quit Smoking for Life Act.
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, and patient navigator programs, H.R. 3293 Labor - HHS Appropriations for FY10.
Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H. R. 756 & S. 660, National Pain Care Policy Act; H. R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 717, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; and S. 488, the Access to Cancer Clinical Trials Act of 2009, and H.R.1740 and S. 994, Breast Cancer Education & Awareness Requires Learning Young Act ("EARLY").
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2009 · third_quarter · Q3
Issues related to smoking cessation, tobacco taxes, and product regulation and implementation, including H.R. 1256, Family Smoking Prevention and Tobacco Control Act, and tobacco tax aspects of H.R. 2, the SCHIP legislation, and H.R. 1850, the Quit Smoking for Life Act.
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations, including H.R. 524 and S. 243, the Giving Incentives to Volunteers Everywhere Act, and tax recommendations included in the President's budget for FY10 to pay for health care reform.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2009 · second_quarter · Q2
Issues related to smoking cessation, tobacco taxes, and product regulation, including H.R. 1256, Family Smoking Prevention and Tobacco Control Act, and tobacco tax aspects of H.R. 2, the SCHIP legislation, and H.R. 1850, the Quit Smoking for Life Act.
Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H. R. 756 & S. 660, National Pain Care Policy Act; H. R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 717, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; and S. 488, the Access to Cancer Clinical Trials Act of 2009, and H.R.1740, the Breast Cancer EARLY Act & issues related to health care reform.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2009 · first_quarter · Q1
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 3042. The Medicare Early Detection of Cancer Promotion Act, and S. 2499 and H.R. 6331. Issues relating to health care reform. Issues relating to tobacco cessation programs within Medicaid.
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, and patient navigator programs, H. Con. Res. 85, House Budget Resolution, and S. Con. Res.13, Senate Budget Resolution, National Cancer Fund legislation, H.R. 1, The American Recovery and Reinvestment Act of 2009, and H.R. 1105, Omnibus appropriations legislation for FY09.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2008 · fourth_quarter · Q4
Issues related to smoking cessation, tobacco taxes and product regulation, including S. 625, H.R. 1108, Family Smoking Prevention and Tobacco Control Act.
Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, wellness, including the following legislation: H.R. 2419, Farm Nutritious & Bioenergy Act of 2007; H.R. 3014, Mental Health Equity & Accountability Act; H.R. 2994, National Pain Care Policy Act; H.R. 1738, Colorectal Cancer Prevention, Early Detection & Treatment Act; proposed Senate national cancer program authorizing legislation; S. 2290 Comprehensive Cancer Improvement Act; S. 2999 & H.R. 2676 Access to Cancer Clinical Trial Act; S. 1415 & H.R. 2353 Cancer Screening Treatment & Survivorship Act; S. 1056 National Cancer Act; S. 400 & H.R. 2851 Michelle's Law Act; and H.R. 2729 Prostate Cancer Research & Prevention Act. Issues related to access to care, including healthcare reform and non-specific legislative advocacy.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2008 · third_quarter · Q3
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 3042. The Medicare Early Detection of Cancer Promotion Act, and S. 2499, and H.R. 6331, and S. 3101 Medicare Improvements for Patients and Providers Act. Issues relating to health care reform.
Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, wellness, including the following legislation: H.R. 2419, Farm Nutritious & Bioenergy Act of 2007; H.R. 3014, Mental Health Equity & Accountability Act; H.R. 2994, National Pain Care Policy Act; H.R. 1738, Colorectal Cancer Prevention, Early Detection & Treatment Act; proposed Senate national cancer program authorizing legislation; S. 2290 Comprehensive Cancer Improvement Act; S. 2999 & H.R. 2676 Access to Cancer Clinical Trial Act; S. 1415 & H.R. 2353 Cancer Screening Treatment & Survivorship Act; S. 1056 National Cancer Act; S. 400 & H.R. 2851 Michelle's Law Act; and H.R. 2729 Prostate Cancer Research & Prevention Act. Issues related to access to care, including healthcare reform and non-specific legislative advocacy.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2008 · second_quarter · Q2
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations.
Issues related to smoking cessation, tobacco taxes and product regulation, including S. 625, H.R. 1108, Family Smoking Prevention and Tobacco Control Act.
Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, wellness, including the following legislation: H.R. 2419, Farm Nutritious & Bioenergy Act of 2007; H.R. 3014, Mental Health Equity & Accountability Act; H.R. 2994, National Pain Care Policy Act; H.R. 1738, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 2290 Comprehensive Cancer Improvement Act; S. 2999 & H.R. 2676 Access to Cancer Clinical Trial Act; S. 1415 & H.R. 2353 Cancer Screening Treatment & Survivorship Act; S. 1056 National Cancer Act; S. 400 & H.R. 2851 Michelle's Law Act; and H.R. 2729 Prostate Cancer Research & Prevention Act. Issues related to access to care, including healthcare reform and non-specific legislative advocacy.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2008 · first_quarter · 1A
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs and patient navigator programs, H. Con. Res. 312, House Budget Resolution, and S. Con. Res. 70, Senate Budget Resolution.
Issues related to smoking cessation, tobacco taxes and product regulation, including S. 625, H.R. 1108, Family Smoking Prevention and Tobacco Control Act.
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 3042. The Medicare Early Detection of Cancer Promotion Act, and S.#2499, and other measures to which Medicare preventative benefits copay waivers may be introduced.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2008 · first_quarter · Q1
Issues relating to the tax treatment of non profits, deductability of non profit donations, and governance of non profit organizations.
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs and patient navigator programs, H. Con. Res. 312, House Budget Resolution, and S. Con. Res. 70, Senate Budget Resolution.
Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, wellness, including the following legislation: H.R. 2419, Farm Nutritious & Bioenergy Act of 2007; H.R. 3014, Mental Health Equity & Accountability Act; H.R. 2994, National Pain Care Policy Act; H.R. 1738, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 1415 & H.R. 2353 Cancer Screening Treatment & Survivorship Act; S. 1056 National Cancer Act; S. 400 & H.R. 2851 Michelle's Law Act; and H.R. 2729 Prostate Cancer Research & Prevention Act. Issues related to access to care, including healthcare reform and non-specific legislative advocacy.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2007 · year_end · YA
Issues relating to the tax treatment of non profits, deductability of non profit donations, and governance of non profit organizations.
Issues related to smoking cessation, tobacco taxes and product regulation including S. 625, H.R. 1108, Family Smoking Prevention and Tobacco Control Act; H.R. 976, S. 1224, H.R. 3963, and S. 1893, the Childrens Health Insurance Reauthorization Act, H.R. 3162, the Children's Health & Medicare Protection Act - and other bill, H.R. 2932 and S. 2005.
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures including H.R. 3042, the Medicare Early Detection of Cancer Promotion Act and S.2499, the Medicare, Medicaid and Children's Health Insurance Program Extension Act.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2007 · year_end · YA
Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, wellness, including the following legislation: S. 624, H.R. 1132, National Breast and Cervical Cancer Early Detection Program Reauthorization Act; H.R. 2419, Farm Nutritious & Bioenergy Act of 2007; H.R. 3014, Mental Health Equity & Accountability Act; H.R. 2994, National Pain Care Policy Act; H.R. 1738, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 1415 & H.R. 2353 Cancer Screening Treatment & Survivorship Act; S. 1056 National Cancer Act; S. 400 & H.R. 2851 Michelle's Law Act; and H.R. 2729 Prostate Cancer Research & Prevention Act. Access to Care. Issues related to healthcare reform, non-specific legislative advocacy.
Federal appropriations for cancer research and programs, including HR 3043, Labor, Health and Human Services, and Education appropriations, H. Con. Res. 99, House Budget Resolution, and S. Con. Res. 21, Senate Budget Resolution - successive fiscal year 2008 appropriations bills including continuing resolutions and HS. Rept. 110-497 to H.R. 2764, the omnibus approps. legislation for FY08.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2007 · year_end · YY
Issues relating to the tax treatment of non profits, deductability of non profit donations, and governance of non profit organizations.
* Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, wellness, including the following legislation: S. 624, H.R. 1132, National Breast and Cervical Cancer Early Detection Program Reauthorization Act; H.R. 2419, Farm Nutritious & Bioenergy Act of 2007. Access to Care. Issues related to healthcare reform, non-specific legislative advocacy. Access to Care. Issues related to healthcare reform, non-specific legislative advocacy.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2007 · mid_year · MM
Federal appropriations for cancer research and programs, including HR 3043, Labor, Health and Human Services, and Education appropriations, H. Con. Res. 99, House Budget Resolution, and S. Con. Res. 21, Senate Budget Resolution.
Issues related to smoking cessation, tobacco taxes and product regulation including S. 625, H.R. 1108, Family Smoking Prevention and Tobacco Control Act, H.R. 976 and S. 3162, the Childrens Health Insurance Reauthorization Act, H.R. 3162, the Children's Health & Medicare Protection Act - and other bill H.R. 2932 and S. 2005.
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Federal budget and appropriations for cancer research and programs, including: FY 2017 and FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act. Also, issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Federal budget and appropriations for cancer research and programs, including: FY 2017 and FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act. Also, issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act.
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; and, H.R.820 & S.292, Childhood Cancer STAR Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including certain votes on issues relating to NIH and cancer moonshot funding in the context of H.R. 2028, the Continuing and Security Assistance Appropriations Act; and, H.R. 34, the 21st Century Cures Act. Also issues relating to non-communicable diseases with respect to S.3117, the State/Foreign Operations FY17 Appropriations legislation, the House companion draft Appropriations bill, and the Continuing Resolution for FY17 enacted prior to October 1, 2016.
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including certain votes on issues relating to NIH and cancer moonshot funding in the context of H.R. 2028, the Continuing and Security Assistance Appropriations Act; and, H.R. 34, the 21st Century Cures Act. Also issues relating to non-communicable diseases with respect to S.3117, the State/Foreign Operations FY17 Appropriations legislation, the House companion draft Appropriations bill, and the Continuing Resolution for FY17 enacted prior to October 1, 2016.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opiod prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act.
Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; and programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H. Con. Res. 25, the FY17 budget resolution, H.R.__, the FY17 Agriculture Appropriations legislation and issues relating to NIH funding in the context of the Senate HELP Committee Medical Innovation legislation.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H.R.6, the 21st Century Cures Act; H.R.3020/S.1695, Departments of Labor HHS Appropriations legislation for FY16; H.R.2772, S.1725, Department of State, Foreign Operations Appropriations for FY16; S.1558, Department of Defense Appropriations Act; and H.R.2029, Mil-Con Veterans Affairs (Omnibus) Appropriations Act.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010. Issues before CMS relating to: Medicare payment for preventive screening; coordinated patient care; care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act of 2015; and H.R.1190, Protecting Seniors' Access to Medicare Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, product regulation, and smokefree environments, including implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430,Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to tobacco control related appropriated accounts, including CDC's Office of Smoking & Health in H.R.2029, Omnibus Appropriations legislation.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010. Issues before CMS relating to: Medicare payment for preventive screening; coordinated patient care; care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act of 2015; and H.R.1190, Protecting Seniors' Access to Medicare Act.
Issues relating to the tax treatment of nonprofits, charitable IRA rollover within tax extenders legislative proposals, including governance of nonprofit organizations.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H.R.6, the 21st Century Cures Act; H.R.3020/S.1695, Departments of Labor HHS Appropriations legislation for FY16; H.R.2772, S.1725, Department of State, Foreign Operations Appropriations for FY16; and S.1558, Department of Defense Appropriations Act.
Issues relating to the tax treatment of nonprofits, deductability of charitable donations within tax extenders legislative proposals, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY16 Budget.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act; an issues before the CDC, including opioid prescription guidelines.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including follow-on legislation to H.R.1666 & S.2800, the Patient Centered Quality Care for Life Act, and, H.R.1339 (IH) & S.641, the Palliative Care and Hospice Education and Training Act (113th Congress), H.R.716 & S.370, the Breast Density & Mammography Reporting Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act.
Issues relating to the tax treatment of nonprofits, deductability of charitable donations within tax extenders legislative proposals, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY16 Budget.
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H.Con.Res.27 & S.Con.Res.11, FY16 proposed budget resolutions; H.R.6, the 21st Century Cures Act; H.R.3020/S.1695, Departments of Labor HHS Appropriations legislation for FY16; H.R.2772, S.1725, Department of State, Foreign Operations Appropriations for FY16; and S.1558S, Department of Defense Appropriations Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations: (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC) and tobacco tax proposals contained in the President's FY16 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership, legislation relating to trade promotion authority, and proposed FDA regulation of electronic cigarettes and/or cigars.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues relating to inclusion of palliative care as a bundled service within CMS quality based payment programs and H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act of 2015; H.R.2810 & H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015 and issues within related to Federally Qualified Health Centers.
Issues relating to the tax treatment of nonprofits, deductability of charitable donations within tax extenders legislative proposals, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY16 Budget.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations: (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and Prevention America Act, H.R.792 & S.772, cigar exemption from FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY15 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership, legislation relating to trade promotion authority, and proposed cigar exemption amendment to Agriculture Appropriations legislation for FY15, H.R.4800 & S.2389, and proposed FDA regulation of electronic cigarettes.
Issues relating to the tax treatment of nonprofits, deductability of charitable donations within tax extenders legislative proposals, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY15 Budget.
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer. Also, un-numbered House & Senate Labor-HHS Appropriations drafts for FY15, H.J.Res. 124, Continuing Appropriations Resolution, 2015, and H.R.83, FY 2015 Omnibus, Consolidated and Further Continuing Appropriations Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer. Also, H.Con.Res. 96, House-passed budget for FY15, un-numbered House & Senate Labor-HHS Appropriations drafts forFY15, and H.J.Res. 124, Continuing Appropriations Resolution, 2015.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", and H.R.1070 & S.2348, Removing Barriers to Colorectal Cancer Screening Act of 2013; H.R.2810, Medicare Patient Access & Quality Improvement Act, S.1871, the SGR Repeal & Medicare BeneficiaryAccess Act, and S. 2157, the Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014.
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY15 Budget.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations: (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and PreventionAmerica Act, H.R.792 & S.772, cigar exemption from FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY15 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership, legislation relating to trade promotion authority, and proposed cigar exemption amendment to Agriculture Appropriations legislation for FY15, H.R.4800 & S.2389.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY15 Budget.
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. President Obama's FY15 budget, S.1284, the FY14 Labor, Health & Human Resources Appropriations Act; H.J.Res.59, Continuing Resolution; H.R.2775,Continuing Appropriations; and H.R.3547, Omnibus Appropriations for FY14, and matters relating to the impact of the government-wide sequester as it affects CDC, NIH, NCI, Prevention & Public Health Fund, and other appropriated accounts relating to cancer.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; H.R.1666, the Patient Centered Quality Care For Life Act, and, H.R.1339 & S.641, the Palliative Care andHospice Education and Training Act; S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.3404, the Breast Density & Mammography Reporting Act, H.R.4250 and S.2141, legislation to create a new FDA approval pathway for O.T.C. sunscreen products.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and global health. President Obama's FY15 budget, S.1284, the FY14 Labor, Health & Human Resources Appropriations Act; and H.R.3547, Omnibus Appropriations for FY14, andmatters relating to the impact of the government-wide sequester as it affects CDC, NIH, NCI, Prevention & Public Health Fund, and other appropriated accounts relating to cancer. Also, H.Con.Res. 96, House-passed budget for FY15, and un-numbered House & Senate Labor-HHS Appropriations drafts for FY15.
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY15 Budget.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", general deficit reduction issues impacting Medicare & Medicaid, and H.R.1070 & S.2348, Removing Barriers to Colorectal Cancer Screening Act of 2013; H.R.2810, Medicare Patient Access & QualityImprovement Act, S.1871, the SGR Repeal & Medicare Beneficiary Access Act, and S. 2157, the Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. President Obama's FY15 budget, S.1284, the FY14 Labor, Health & Human Resources Appropriations Act; H.J.Res.59, Continuing Resolution; H.R.2775,Continuing Appropriations; and H.R.3547, Omnibus Appropriations for FY14, and matters relating to the impact of the government-wide sequester as it affects CDC, NIH, NCI, Prevention & Public Health Fund, and other appropriated accounts relating to cancer.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", general deficit reduction issues impacting Medicare & Medicaid, and H.R.1070, Removing Barriers to Colorectal Cancer Screening Act of 2013; H.R.2810, Medicare Patient Access & QualityImprovement Act, S.1871, the SGR Repeal & Medicare Beneficiary Access Act, and S. 2157, the Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and Prevention America Act, H.R.792 & S.772, cigar exemptionfrom FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY15 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership, and legislation relating to trade promotion authority.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and Prevention America Act, H.R.792 & S.772, cigar exemptionfrom FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership, and legislation relating to trade promotion authority.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", general deficit reduction issues impacting Medicare & Medicaid, and H.R.1070, Removing Barriers to Colorectal Cancer Screening Act of 2013; H.R.2810, Medicare Patient Access & QualityImprovement Act and S.1871, the SGR Repeal & Medicare Beneficiary Access Act.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; H.R.1666, the Patient Centered Quality Care For Life Act, and, H.R.1339 & S.641, the Palliative Care andHospice Education and Training Act; S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.3404, the Breast Density & Mammography Reporting Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. The President's FY14 Budget; and S.1284, the FY14 Labor, Health & Human Resources Appropriations Act, and matters relating to the impact of the government-widesequester as it affects CDC, NIH, NCI, Prevention & Public Health Fund, and other appropriated accounts relating to cancer.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", general deficit reduction issues impacting Medicare & Medicaid, and H.R.1070, Removing Barriers to Colorectal Cancer Screening Act of 2013.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and Prevention America Act, H.R.792 & S.772, cigar exemptionfrom FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act; S. 621 and H.R. 1285, the Safe Prescribing Act;H.R. 1366, the Stop Oxy Abuse Act; and issues relating to tanning beds before the FDA, HHS and the House and Senate.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid, including: S.868 and H.R.1683, the State Flexibility Act (MOE). Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", general deficit reduction issues impacting Medicare & Medicaid, and H.R.1070, Removing Barriers to Colorectal Cancer Screening Act of 2013.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office
Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, the Clean Cookstoves Support Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act and H.R. 1070, Reducing Barriersto Colorectal Cancer Screening Act and S. 621 and H.R. 1285, the Safe Prescribing Act and H.R. 1366, the Stop Oxy Abuse Act.
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. S.Con.Res. 8 FY14 Senate Budget Resolution, H.R. 993 Consolidated & Further Continuing Appropriations Act of 2013. H.J.Res.117, the Continuing AppropriationsResolution Act; and the President's FY14 Budget.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. S.Con.Res. 8 FY14 Senate Budget Resolution, H.J.Res.117, the Continuing Appropriations Resolution Act; the President's FY14 Budget; and S.1284, the FY14 Labor,Health & Human Resources Appropriations Act.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid, including: S.868 and H.R.1683, the State Flexibility Act (MOE). Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", general deficit reduction issues impacting Medicare & Medicaid, and H.R.1070, Removing Barriers to Colorectal Cancer Screening Act of 2013.
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY14 Budget.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office
Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, the Clean Cookstoves Support Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act and H.R. 1070, Reducing Barriersto Colorectal Cancer Screening Act and S. 621 and H.R. 1285, the Safe Prescribing Act and H.R. 1366, the Stop Oxy Abuse Act.
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. S.Con.Res. 8 FY14 Senate Budget Resolution, H.R. 993 Consolidated & Further Continuing Appropriations Act of 2013. H.J.Res.117, the Continuing AppropriationsResolution Act; and the President's FY14 Budget.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid, including: S.868 and H.R.1683, the State Flexibility Act (MOE). Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", S.2068, S.2288, H.R.1206, the Access to Independent Health Insurance Advisors Act of 2012, general deficit reduction issues impacting Medicare &Medicaid.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office
Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid, including: S.868 and H.R.1683, the State Flexibility Act (MOE). Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", S.2068, S.2288, H.R.1206, the Access to Independent Health Insurance Advisors Act of 2012, general deficit reduction issues impacting Medicare & Medicaid.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC); and (4) issues relating to NIH reorganization. Legislation includes H.R.3186 and S.1706, Smuggled Tobacco Prevention Act; H.R.3382, Smoke-Free Federal Building Act; S.1403, IDEA Full Funding Act; and H.R.65: Candy Tobacco Tax Parity Act of 2011. Issues related to cigar regulation on H.R.5973. Issues relating to tobacco and trade, including the Trans-Pacific Partnership.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office
Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, and international health. H.J.Res.117, the Continuing Appropriations Resolution Act; S.3295, the Labor, HHS, Education Appropriations Act, and similar legislation pending in the House of Representatives.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid, including: S.868 and H.R.1683, the State Flexibility Act (MOE). Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", S.2068, S.2288, H.R.1206, the Access to Independent Health Insurance Advisors Act of 2012, general deficit reduction issues impacting Medicare & Medicaid.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC (S.3295); the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, and international health. Legislation includes H. Con. Res. 34, establishing the budget for the US Government for FY 2012; and issues relating to consolidation of categorized cancer prevention programs of the Centers for Disease Control and Prevention.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid, including: S.868 and H.R.1683, the State Flexibility Act (MOE). Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing".
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, governance of nonprofit organizations, the Public Good IRA Rollover Act, S. 557, legislation relating to tax extenders, and issues under consideration by the Joint Select Committee on Deficit Reduction.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) legislation regarding Congressional review/approval of regulations, including H.R.10, the Regulations from the Executive in Need of Scrutiny Act of 2011; (4) Framework Convention on Tobacco Control (FCTC); and (5) issues relating to NIH reorganization. Legislation includes H.R.3186 and S.1706, Smuggled Tobacco Prevention Act; H.R.3382, Smoke-Free Federal Building Act; S.1403, IDEA Full Funding Act; and H.R.65: Candy Tobacco Tax Parity Act of 2011. Issues related to cigar regulation on H.R.5973.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office
Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493; H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R. 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S. 1064, the Sun Act; S 965, the Family Act; H.R. 2954, Health Equity and Accountability Act of 2011; and H.R. 2077, the MLR Repeal Act; H.R. 2245 and S. 296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R. 4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act.
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, governance of nonprofit organizations, the Public Good IRA Rollover Act, S. 557, legislation relating to tax extenders, and issues under consideration by the Joint Select Committee on Deficit Reduction.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) legislation regarding Congressional review/approval of regulations, including H.R. 10, the Regulations from the Executive in Need of Scrutiny A Act of 2011; (4) Framework Convention on Tobacco Control (FCTC); and (5) issues relating to NIH reorganization. Legislation includes H.R. 3186 and S. 1706, Smuggled Tobacco Prevention Act; H.R. 3382, Smoke-Free Federal Building Act; S. 1403, IDEA Full Funding Act; and H.R. 65: Candy Tobacco Tax Parity Act of 2011.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), White House Office
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid, including: S. 868 and H.R. 1683, the State Flexibility Act (MOE); and matters under consideration by the Joint Select Committee on Deficit Reduction.
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, and international health; and matters under consideration by the Joint Select Committee on Deficit Reduction. Legislation includes H. Con. Res. 34, establishing the budget for the US Government for FY 2012; S. 1599, legislation including draft House text of legislation making appropriations for L-HHS FY 12; H.R. 2055 and S. 3671, Consolidated Appropriations Act of 2012.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) legislation regarding Congressional review/approval of regulations, including H.R. 10, the Regulations from the Executive in Need of Scrutiny A Act of 2011; (4) Framework Convention on Tobacco Control (FCTC); and (5) issues relating to NIH reorganization. Legislation includes H.R. 3186 and S. 1706, Smuggled Tobacco Prevention Act; H.R. 3382, Smoke-Free Federal Building Act; S. 1403, IDEA Full Funding Act; and H.R. 65: Candy Tobacco Tax Parity Act of 2011.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), White House Office
Issues relating to the tax treatment of nonprofits, deductability of charitable donations, governance of nonprofit organizations, the Public Good IRA Rollover Act, S. 557, legislation relating to tax extenders, and issues under consideration by the Joint Select Committee on Deficit Reduction.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid, including: S. 717 and H.R. 6224; H. Con. Res. 34, establishing a budget for the US Government for FY 12; S. 868 and H.R. 1683, the State Flexibility Act (MOE); and matters under consideration by the Joint Select Committee on Deficit Reduction.
Issues relating to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S 494 and HR 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; HR 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; HR 1217, Repeal Prevention and Public Health Fund; HR 1740 and HR 5560, the Quality Cancer Care for Life Act of 2010; HR 2941 and S 3493; HR 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; HR 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S. 1064, the Sun Act; S 965, the Family Act; HR2954, Health Equity and Accountability Act of 2011; and HR 2077, the MLR Repeal Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), White House Office
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations, and the Public Good IRA Rollover Act, S.557, legislation relating to tax extenders.
Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.494, and H.R.912; H.R.1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R.1217, Repeal Prevention & Public Health Fund; S.488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R.5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493, H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.2366, the Cancer Drug Coverage Act of 2009; H.R.4662, The Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act, and H.R.2077, the MLR Repeal Act.
Issues related to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L.111-31); (2) cessation and prevention programs authorized as part of P.L.111-148, the Patient Protection & Affordable Care Act of 2010; (3) legislation regarding Congressional review/approval of regulations, including H.R.10, the Regulations from the Executive in Need of Scrutiny Act of 2011; (4) Framework Convention on Tobacco Control (FCTC); and (5) issues relating to NIH reorganization.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), White House Office
Federal budget and appropriations for cancer research and programs, including federal appropriations for the Prevention & Public Health Fund, the Affordable Care Act provisions, breast and cervical programs, colorectal cancer programs, tobacco regulation & cessation programs, patient navigator programs, and international health programs, including S.3686, the Senate Labor-HHS appropriations for FY11, each of the continuing resolutions making appropriations for FY11, H.R.1473 making remaining appropriations for FY11, H. Con. Res. 34, establishing the budget for the U.S. Government for FY 2012.
Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.494, and H.R.912; H.R.1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R.1217, Repeal Prevention & Public Health Fund; S.488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R.5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493, Johanna's Law reauthorization; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.2366, the Cancer Drug Coverage Act of 2009; H.R.4662, The Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010; and child nutrition reauthorization bills (H.R.5504, Improving Nutrition for America's Children Act, and S.3307, Healthy, Hunger-Free Kids Act).
Issues related to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including implementation of the Family Smoking Prevention and Tobacco Control Act (P.L.111-31), and cessation and prevention programs authorized as part of P.L.111-148, the Patient Protection & Affordable Care Act of 2010, legislation regarding Congressional review/approval of regulations, including H.R.10, the Regulations from the Executive in Need of Scrutiny Act of 2011 , and Framework Convention on Tobacco Control (FCTC), and issues relating to NIH reorganization.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), White House Office
Issues related to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including implementation of the Family Smoking Prevention and Tobacco Control Act (P.L.111-31), H.R.1850, the Quit Smoking for Life Act, and related cessation legislation, and cessation and prevention programs authorized as part of P.L.111-148, the Patient Protection & Affordable Care Act of 2010, the Prevent All Cigarette Trafficking Act (PACT Act - H.R.1676 and S.1147), and the Framework Convention on Tobacco Control (FCTC), and issues relating to NIH reorganization.
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, tobacco regulation & cessation programs, patient navigator programs, and international health programs, including S.3686, the Senate Labor-HHS appropriations for FY11, and Senate Amendment to H.3081, H.J. Res.101, H.J. Res.105 and H.3082, the 1st, 2nd, 3rd, and 4th Continuing Appropriations Act, 2011.
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations, including H.R.524 and S.243, the Giving Incentives to Volunteers Everywhere Act, and legislation relating to tax extenders and the estate tax, H.R.5533, the Nonprofit Sector and Community Solutions Act, and H.R.5297, the Tax Treatment of Employer Provided Cell Phones.
Issues related to implementation of changes to Medicare and Medicaid, pursuant to P.L.111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S.717 and H.R.6224, the 21st Century Cancer ALERT Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), White House Office
Issues related to health care reform, Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R.2291, the Medicare Early Detection of Cancer Promotion Act. Issues relating to implentation of Medicare & Medicaid related provisions enacted as part of P.L.111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S.717 and H.R.6224, the 21st Century Cancer ALERT Act.
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations, including H.R.524 and S.243, the Giving Incentives to Volunteers Everywhere Act, and legislation relating to tax extenders and the estate tax.
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, tobacco regulation & cessation programs, patient navigator programs, and international health programs, including S.3686, the Senate Labor-HHS appropriations for FY11, and the comparable unnamed House bill.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), White House Office
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, and patient navigator programs, including H. Con. Res. 85 and S. Con. Res. 13, the House & Senate Budget Resolution and Labor-HHS appropriations for FY11, as yet not introduced.
Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H. R. 756 & S. 660, National Pain Care Policy Act; H. R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 717, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; S. 488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; and the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010..
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations, including H.R. 524 and S. 243, the Giving Incentives to Volunteers Everywhere Act, and legislation relating to tax extenders and the estate tax.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations, including H.R. 524 and S. 243, the Giving Incentives to Volunteers Everywhere Act.
Issues related to health care reform, Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 2291, the Medicare Early Detection of Cancer Promotion Act. Issues relating to Medicare & Medicaid in H.R. 3590 The Patient Protection & Affordable Care Act and H.R. 4872, the Health Care & Education Reconciliation Act of 2010, the health care reform bills. Issues relating to tobacco cessation programs within Medicaid, including S. 717 the 21st Century Cancer ALERT Act.
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, and patient navigator programs, to be included in legislation as yet un-numbered..
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 2291, the Medicare Early Detection of Cancer Promotion Act. Issues relating to Medicare & Medicaid in HR 3590 & HR 3962, the House & Senate health care reform bills. Issues relating to tobacco cessation programs within Medicaid, including S. 717 the 21st Century Cancer ALERT Act.
Issues related to smoking cessation, tobacco taxes, and product regulation and implementation, including H.R. 1256, Family Smoking Prevention and Tobacco Control Act, and H.R. 1850, the Quit Smoking for Life Act.
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations, including H.R. 524 and S. 243, the Giving Incentives to Volunteers Everywhere Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations, including H.R. 524 and S. 243, the Giving Incentives to Volunteers Everywhere Act, and tax recommendations included in the President's budget for FY10 to pay for health care reform.
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 2291, the Medicare Early Detection of Cancer Promotion Act. Issues relating to Medicare & Medicaid in the House & Senate health care reform bills. Issues relating to tobacco cessation programs within Medicaid, including S. 717 the 21st Century Cancer ALERT Act.
Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H. R. 756 & S. 660, National Pain Care Policy Act; H. R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 717, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; and S. 488, the Access to Cancer Clinical Trials Act of 2009, and H.R.1740 and S. 994, Breast Cancer Education & Awareness Requires Learning Young Act ("EARLY").
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations, including H.R. 524 and S. 243, the Giving Incentives to Volunteers Everywhere Act, and tax recommendations included in the President's budget for FY10 to pay for health care reform.
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 2291, the Medicare Early Detection of Cancer Promotion Act. Issues relating to Medicare & Medicaid in the House & Senate health care reform bills. Issues relating to tobacco cessation programs within Medicaid, including S. 717 the 21st Century Cancer ALERT Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 2291, the Medicare Early Detection of Cancer Promotion Act. Issues relating to Medicare & Medicaid in the House & Senate health care reform bills. Issues relating to tobacco cessation programs within Medicaid, including S. 717 the 21st Century Cancer ALERT Act.
Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H. R. 756 & S. 660, National Pain Care Policy Act; H. R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 717, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; and S. 488, the Access to Cancer Clinical Trials Act of 2009, and H.R.1740 and S. 994, Breast Cancer Education & Awareness Requires Learning Young Act ("EARLY").
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, and patient navigator programs, H.R. 3293 Labor - HHS Appropriations for FY10.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, and patient navigator programs, H. Con. Res. 85, House Budget Resolution, and S. Con. Res.13, Senate Budget Resolution, National Cancer Fund legislation, H.R. 1, The American Recovery and Reinvestment Act of 2009, and H.R. 1105, Omnibus appropriations legislation for FY09, Labor - HHS Appropriations for FY10.
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 2291, the Medicare Early Detection of Cancer Promotion Act. Issues relating to health care reform. Issues relating to tobacco cessation programs within Medicaid, including S. 717 the 21st Century Cancer ALERT Act.
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations, including H.R. 524 and S. 243, the Giving Incentives to Volunteers Everywhere Act, and tax recommendations included in the President's budget for FY10 to pay for health care reform.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to smoking cessation, tobacco taxes, and product regulation, including H.R. 1256, Family Smoking Prevention and Tobacco Control Act, and tobacco tax aspects of H.R. 2, the SCHIP legislation, and H.R. 1850, the Quit Smoking for Life Act.
Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R. 756 & S. 660, National Pain Care Policy Act; H.R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 717, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; and S. 488, the Access to Cancer Clinical Trials Act of 2009. Issues related to access to care, including health care reform.
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations, including H.R. 524 and S. 243, the Giving Incentives to Volunteers Everywhere Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 3042. The Medicare Early Detection of Cancer Promotion Act, and S. 2499, and H.R. 6331, and S. 3101 Medicare Improvements for Patients and Providers Act. Issues relating to health care reform.
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs and patient navigator programs, H. Con. Res. 312, House Budget Resolution, and S. Con. Res. 70, Senate Budget Resolution, Supplemental appropriations H.R. 2642, S.3230 making FY09 appropriations for Labor, Health & Human Services, and HR 6791, the National Cancer Fund Act, and assorted economic stimulus legislative proposals.
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues relating to the tax treatment of non-profits, deductability of non-profit donations, and governance of non-profit organizations.
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs and patient navigator programs, H. Con. Res. 312, House Budget Resolution, and S. Con. Res. 70, Senate Budget Resolution, Supplemental appropriations H.R. 2642, S.3230 making FY09 appropriations for Labor, Health & Human Services, and HR 6791, the National Cancer Fund Act.
Issues related to smoking cessation, tobacco taxes and product regulation, including S. 625, H.R. 1108, Family Smoking Prevention and Tobacco Control Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 3042. The Medicare Early Detection of Cancer Promotion Act, and S. 2499, and H.R. 6331, and S. 3101 Medicare Improvements for Patients and Providers Act. Issues relating to health care reform.
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs and patient navigator programs, H. Con. Res. 312, House Budget Resolution, and S. Con. Res. 70, Senate Budget Resolution, Supplemental appropriations H.R. 2642, and House and Senate unnumbered appropriations bills for Labor, Health & Human Services.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, wellness, including the following legislation: H.R. 2419, Farm Nutritious & Bioenergy Act of 2007; H.R. 3014, Mental Health Equity & Accountability Act; H.R. 2994, National Pain Care Policy Act; H.R. 1738, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 1415 & H.R. 2353 Cancer Screening Treatment & Survivorship Act; S. 1056 National Cancer Act; S. 400 & H.R. 2851 Michelle's Law Act; and H.R. 2729 Prostate Cancer Research & Prevention Act. Issues related to access to care, including healthcare reform and non-specific legislative advocacy.
Issues relating to the tax treatment of non profits, deductability of non profit donations, and governance of non profit organizations.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 3042. The Medicare Early Detection of Cancer Promotion Act, and S.#2499, and other measures to which Medicare preventative benefits copay waivers may be introduced.
Issues related to smoking cessation, tobacco taxes and product regulation, including S. 625, H.R. 1108, Family Smoking Prevention and Tobacco Control Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, wellness, including the following legislation: S. 624, H.R. 1132, National Breast and Cervical Cancer Early Detection Program Reauthorization Act; H.R. 2419, Farm Nutritious & Bioenergy Act of 2007; H.R. 3014, Mental Health Equity & Accountability Act; H.R. 2994, National Pain Care Policy Act; H.R. 1738, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 1415 & H.R. 2353 Cancer Screening Treatment & Survivorship Act; S. 1056 National Cancer Act; S. 400 & H.R. 2851 Michelle's Law Act; and H.R. 2729 Prostate Cancer Research & Prevention Act. Access to Care. Issues related to healthcare reform, non-specific legislative advocacy.
Federal appropriations for cancer research and programs, including HR 3043, Labor, Health and Human Services, and Education appropriations, H. Con. Res. 99, House Budget Resolution, and S. Con. Res. 21, Senate Budget Resolution - successive fiscal year 2008 appropriations bills including continuing resolutions and HS. Rept. 110-497 to H.R. 2764, the omnibus approps. legislation for FY08.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, UNDETERMINED, White House Office
Issues relating to the tax treatment of non profits, deductability of non profit donations, and governance of non profit organizations.
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures including H.R. 3042, the Medicare Early Detection of Cancer Promotion Act and S.2499, the Medicare, Medicaid and Children's Health Insurance Program Extension Act.
Issues related to smoking cessation, tobacco taxes and product regulation including S. 625, H.R. 1108, Family Smoking Prevention and Tobacco Control Act; H.R. 976, S. 1224, H.R. 3963, and S. 1893, the Childrens Health Insurance Reauthorization Act, H.R. 3162, the Children's Health & Medicare Protection Act - and other bill, H.R. 2932 and S. 2005.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, UNDETERMINED, White House Office
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures including H.R. 3042, the Medicare Early Detection of Cancer Promotion Act and S.2499, the Medicare, Medicaid and Children's Health Insurance Program Extension Act.
Federal appropriations for cancer research and programs, including HR 3043, Labor, Health and Human Services, and Education appropriations, H. Con. Res. 99, House Budget Resolution, and S. Con. Res. 21, Senate Budget Resolution - successive fiscal year 2008 appropriations bills including continuing resolutions and HS. Rept. 110-497 to H.R. 2764, the omnibus approps. legislation for FY08.
Issues related to smoking cessation, tobacco taxes and product regulation including S. 625, H.R. 1108, Family Smoking Prevention and Tobacco Control Act; H.R. 976, S. 1224, H.R. 3963, and S. 1893, the Childrens Health Insurance Reauthorization Act, H.R. 3162, the Children's Health & Medicare Protection Act - and other bill, H.R. 2932 and S. 2005.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
* Access to Care. Issues related to healthcare reform, non-specific legislative advocacy. H.R. 3014, Mental Health Equity & Accountability Act; H.R. 2994, National Pain Care Policy Act; H.R. 1738, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 1415 & H.R. 2353 Cancer Screening Treatment & Survivorship Act; S. 1056 National Cancer Act; S. 400 & H.R. 2851 Michelle's Law Act; and H.R. 2729 Prostate Cancer Research & Prevention Act. Issues related to health disparities, federal health care programs, genetic information, cancer, nutrition, wellness, including the following legislation: S. 624, H.R. 1132, National Breast and Cervical Cancer Early Detection Program Reauthorization Act; H.R. 2419, Farm Bill Extension Act; 5
Issues relating to the tax treatment of non profits, deductability of non profit donations, and governance of non profit organization.
Issues related to Medicare and Medicaid coverage of cancer-related services and prevention measures including H.R. 3042, the Medicare Early Detection of Cancer Promotion Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office